Page 28 - Wondergem

Chapter 1
67. Hohloch K, Sahlmann CO, Lakhani VJ et al. Tandem high-dose therapy in relapsed and refractory B-cell lymphoma: results of a prospective phase II trial of myeloablative chemotherapy followed by escalated radioimmunotherapy with 131I-anti-CD20 antibody and stem cell rescue. Ann Hematol 2011;90:1307-1315
68. Krishnan A, Nademannee A, Fung HC et al. Phase II trial of a transplantation regimen of yttrium-90- ibritumoab tiuxetan and high-dose chemotherapy in patients with non-Hodgkin’s lymphoma. J Clin Oncol 2008;26:90-95
69. Wondergem MJ, Zijlstra JM, de Rooij M, Visser OJ, Huijgens PC, Zweegman S. Improving survival in patients with transformed B-cell non Hodgkin lymphoma: consolidation with 90Yttrium ibritumomab tiuxetan- BEAM and autologous stem cell transplantation. Br Journal of Haematol 2012; 157(3): 395-397
70. Ban-Hoeffen M, Kelly JL, Bernstein SH, et al. High-dose therapy and autologous stem cell transplant for transformed non-hodgkin lymphoma in the rituximab era. Leuk Lymphoma 2012;53(5):830-835
71. Bastion Y, Brice P, Haioun C, et al. Intensive therapy with peripheral blood progenitor cell transplantation in 60 patients with poor prognosis follicular lymphoma. Blood 1995;86:3257-3265
72. Berglund A, Enblad G, Karlson K et al. Long-term follow-up of autologous stem-cell transplantations for follicular and transformed follicular lymphoma. Eur J Haematol 2000;65:17-22
73. Blystadt AK, Kvalheim G, Torlakovic E. High-dose therapy supported with immunomagnetic purged autologous bone marrow in high-grade B cell non Hodgkin’s lymphoma. Bone Marrow Transplant 1999;24:865-872
74. Cao TM, Horning SJ, Negrin RS et al. High-dose therapy and autologous hematopoietic-cell transplantation for Follicular Lymphoma beyond first remission: the Stanford University experience. Biol Blood Marrow Transplant 2001;7:294-301
75. CarracioloD,GavarottiP,AgliettaM,etal.Highdosesequentialchemotherapywithbloodandmarrowcell autograft as salvage treatment in very poor prognosis, relapsed non-Hodgkin’s lymphoma. Bone Marrow Transplant 1993;12:621-625
76. Chen CI, Crump M, Tsang R et al. Autotransplants for histologically transformed follicular non-Hodgkin’s lymphoma. Br J Haematol 2001;113(1):202-208
77. Eide MB, Lauritzsen GF, Kvalheim G et al. High dose chemotherapy with autologous stem cell support for patients with histologically transformed B-cell non Hodgkin Lymphomas. A Norwegian multi center phase II study. Br J Haematol. 2011;152(5):600-610
78. Foran JM, Apostolidis J, Papamichael D et al. High-dose therapy with autologous haematopoietic support in patients with transformed follicular lymphoma: a study of 27 patients from a single centre. Ann Oncol 1998;9(8):865-869
79. Le Gouill S, Moreau P, Morineau N et al. Tandem high-dose therapy followed by autologous stem-cell transplantation for refractory or relapsed high grade non-Hodgkin’s lymphoma with poor prognosis factors: a prospective pilot study. Haematol. 2002;87(3):333-334
80. Hamadani M, Benson DM, Lin TS et al. High-dose therapy and autologous stem cell transplantation for follicular lymphoma undergoing transformation to diffuse large B-cell lymphoma. Eur J Haematol. 2008;81(6):425-431
81. Holman PR, Costello C, de Magalhaes-Silverman M et al. Idiotype immunization following high-dose therapy and autologous stem cell transplantation for non Hodgkin lymphoma. Biol Blood Marrow Transplant 2012;18:257-264
82. Kasamon YL, Jones RJ, Gocke CD et al. Extended follow-up of autologous bone marrow transplantation with 4-hydroperoxycyclophosphamide purging for indolent or transformed non-Hodgkin lymphomas. Biol Blood Marrow Transplant 2011;17:365-373
83. Laudi N, Arora M, Burns LJ et al. Long-term follow-up after autologous hematopoietic stem cell transplantation for low-grade non-Hodgkin lymphoma. Biol Blood Marrow Transplant 2005;11:129-135
84. Sabloff M, Atkins HL, Bence-Bruckner I et al. A 15-year analysis of early and late autologous hematopoietic stem cell transplant in relapsed, aggressive, transformed and non-transformed follicular lymphoma. Biol Blood Marrow Transplant 2007;13(8):956-964
85. Schouten H, Bierman PJ, Vaughan WP et al. Autologous stem cell transplantation in follicular lymphoma before and after histologic transformation. Blood 1989;74:2579-2584
86. Smith SD, Bolwell BJ, Advani AS et al. High rate of survival in transformed lymphoma after autologous stem cell transplant: pathologic analysis and comparison with de novo diffuse large B-cell lymphoma. Leuk Lymphoma 2009;50(10):1625-1631
26